コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ratoire d'Excellence Integrative "Biology of Emerging Infectious Diseases".
2 ce Centers for Biodefense and Emerging or Re-Emerging Infectious Diseases'.
3 nt recent instance of spatial invasion by an emerging infectious disease.
4 milar to smallpox and is considered to be an emerging infectious disease.
5 respiratory syndrome (SARS) is a significant emerging infectious disease.
6 accelerated the understanding of this newly emerging infectious disease.
7 ssential for preventing and/or treating this emerging infectious disease.
8 s to a treatment is needed in response to an emerging infectious disease.
9 th strategy when confronted with a dangerous emerging infectious disease.
10 veys are conducted in the context of a newly emerging infectious disease.
11 short- and long-term protection against this emerging infectious disease.
12 of potential pathogens is crucial to control emerging infectious disease.
13 rus transmission is critical to anticipating emerging infectious diseases.
14 could provide an important novel therapy for emerging infectious diseases.
15 ent of plant-derived mAbs as therapy against emerging infectious diseases.
16 that can elicit protective immunity against emerging infectious diseases.
17 ategies against a variety of established and emerging infectious diseases.
18 just two of the most widely reported recent emerging infectious diseases.
19 Asia remains vulnerable to new and emerging infectious diseases.
20 ss to respond effectively to emerging and re-emerging infectious diseases.
21 s wildlife is crucial for risk assessment of emerging infectious diseases.
22 advancement of immunotherapeutics targeting emerging infectious diseases.
23 tial medications against the emerging and re-emerging infectious diseases.
24 thogen interactions and changing the risk of emerging infectious diseases.
25 r designing appropriate control measures for emerging infectious diseases.
26 fective strategies to mitigate the impact of emerging infectious diseases.
27 clinical implementation is critical such as emerging infectious diseases.
28 cy and rapid deployment capability to target emerging infectious diseases.
29 improved or new vaccines against existing or emerging infectious diseases.
30 are necessary to obtain robust forecasts for emerging infectious diseases.
31 -US Collaborative Program on Emerging and Re-emerging Infectious Diseases.
32 d and scavenging animals, creates a risk for emerging infectious diseases.
33 ce knowledge to prevent the spread of future emerging infectious diseases.
34 pid development of screening tools for novel emerging infectious diseases.
35 psy post-mortem in investigating endemic and emerging infectious diseases.
36 only pandemic preparedness but also against emerging infectious diseases.
37 al to understanding the risks and control of emerging infectious diseases.
38 ation and aid in the control of zoonotic and emerging infectious diseases.
39 erves as a paradigm for preparing for future emerging infectious diseases.
40 c health issue, especially with outbreaks of emerging infectious diseases.
41 e, rapid diagnosis and real-time tracking of emerging infectious diseases.
42 rch and development blueprint initiative for emerging infectious diseases.
43 tool for timely vaccine development against emerging infectious diseases.
44 patients with EVD and other high-consequence emerging infectious diseases.
45 , and equipment to rapidly identify rare and emerging infectious diseases.
46 es are a significant class of agents causing emerging infectious diseases.
47 rating or even preventing the spread of such emerging infectious diseases.
48 modeling pathogen-host interactions in other emerging infectious diseases.
49 n the ecological dynamics of established and emerging infectious diseases.
50 can be extended to other taxa threatened by emerging infectious diseases.
51 Wildlife is a global source of endemic and emerging infectious diseases.
52 are often the first available therapy for an emerging infectious disease, a stopgap treatment while n
55 nfection, has recently been identified as an emerging infectious disease affecting wild tit species i
57 ends to understanding the spread of novel or emerging infectious disease, an alternative approach to
58 n to the far-reaching social implications of emerging infectious diseases, an issue with historical p
59 ealth concerns about the dissemination of an emerging infectious disease and highlights the need for
60 to test whether chronic bee paralysis is an emerging infectious disease and investigate the spatiote
61 hese methodologies is essential for tackling emerging infectious diseases and advancing therapeutic d
62 also potential for climate-driven impacts on emerging infectious diseases and antimicrobial resistanc
64 routine specimen screening surveillance for emerging infectious diseases and of joint integration of
65 c strategies to identify etiologic agents of emerging infectious diseases and once again demonstrates
66 to understand host responses and immunity to emerging infectious diseases and potential bioterrorism
67 treatment option for EBOV disease.IMPORTANCE Emerging infectious diseases are a major public health c
78 ic, that are rapidly scalable in response to emerging infectious diseases, are essential for both the
79 vere acute respiratory syndrome (SARS) is an emerging infectious disease associated with a high rate
80 ogenies are most often found in the field of emerging infectious diseases, but will become increasing
83 Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by a novel coronaviru
84 s human risk of exposure to ehrlichiosis, an emerging infectious disease caused by bacterial pathogen
87 rus disease 2019 (COVID-19) is defined as an emerging infectious disease caused by severe acute respi
92 nificant threat to amphibians is a virulent, emerging infectious disease, chytridiomycosis, which app
95 arge-scale population declines globally, and emerging infectious diseases contribute heavily to these
96 a paradigm shift in our understanding of how emerging infectious diseases contribute to global patter
99 to investigate and control outbreaks, detect emerging infectious diseases, develop vaccines, and comb
100 bial cell-free DNA (mcfDNA) sequencing is an emerging infectious disease diagnostic tool which enable
101 diseases in Hong Kong which is a hotspot for emerging infectious diseases due to its high population
102 leucopus as a model organism for studies of emerging infectious diseases, ecology, and in other disc
104 rstanding of the current and ongoing risk of emerging infectious disease (EID) transmission between m
120 ted within 27 y to reduce the annual rise of emerging infectious disease events by 50% at an estimate
122 a fungus causing one of the most devastating emerging infectious disease ever recorded among vertebra
123 affeensis is a life-threatening, tick-borne, emerging infectious disease for which no satisfactory an
125 veillance plays a crucial role in preventing emerging infectious diseases from becoming epidemic.
127 s exhibited lower average growth rates, this emerging infectious disease has the potential to reduce
133 cing has become a powerful tool for studying emerging infectious diseases; however, genome sequencing
134 terium that invades neutrophils to cause the emerging infectious disease human granulocytic anaplasmo
140 ak, as well as inevitable outbreaks of other emerging infectious diseases in China's Pearl River Delt
144 and the public health impact resulting from emerging infectious diseases including the ongoing COVID
145 ats are a major reservoir of emerging and re-emerging infectious diseases, including severe acute res
152 n and spread or potential aerosol release of emerging infectious diseases, it will be critical to dev
153 (ANR-10-IAHU-01), the Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (A
154 double-stranded DNA (dsDNA) viruses causing emerging infectious diseases leading to extensive morbid
157 outheastern Asia is a recognised hotspot for emerging infectious diseases, many of which have an anim
160 e Centers for Disease Control and Prevention Emerging Infectious Diseases Network, and infectious dis
161 dscape, we assess for the first time how two emerging infectious diseases (Nosema sp. and the Varroa-
162 onal Centers of Excellence in Biodefense and Emerging Infectious Diseases (NSRB) against BasE, an AAA
164 Papillomatous digital dermatitis (PDD), an emerging infectious disease of cattle, is characterized
166 abesiosis has recently been recognized as an emerging infectious disease of dogs in North America.
172 ns is critical for mitigating the impacts of emerging infectious diseases on economically and ecologi
173 rstanding of the evolving social dynamics of emerging infectious diseases ought to help us to anticip
179 need to monitor the changing consequences of emerging infectious diseases over time and the importanc
181 tion that has recently been identified as an emerging infectious disease particularly affecting an ab
182 een long used as a public health response to emerging infectious diseases, particularly at the onset
183 c liver abscess (PLA) is becoming a globally emerging infectious disease, population-based investigat
184 cale and rapidity of dissemination of recent emerging infectious diseases pose new challenges for vac
187 vCJD was recently identified as one of three emerging infectious diseases posing the greatest immedia
188 f astrovirus (TAstV-2) from turkeys with the emerging infectious disease poult enteritis mortality sy
189 ogy pipeline, including immune responses and emerging infectious disease prediction, manufacturing an
196 estigations to address the public health and emerging infectious disease risks associated with bushme
197 can contribute to immune protection against emerging infectious disease risks such as antimicrobial-
198 artonellosis, a potentially life-threatening emerging infectious disease seen in the Andes Mountains
202 ng chronic diseases such as hypertension and emerging infectious diseases such as coronavirus disease
206 d in the development of repurposed drugs for emerging infectious diseases such as, but not limited to
207 eneralist parasites are more likely to cause emerging infectious diseases, such biotic homogenisation
208 le diagnostics are inadequate and supplement emerging infectious disease surveillance systems to ensu
212 ting and often dramatic reports of so-called emerging infectious diseases, the media have largely ign
213 As we start unravelling the full extent of emerging infectious diseases, there is an urgent need to
214 ected climate changes are thought to promote emerging infectious diseases, though to date, evidence l
215 lp public health officials plan for the next emerging infectious disease threat.The last 18 months ha
216 and large number of potential hosts of this emerging infectious disease threaten global amphibian di
217 me sets a new standard for rapid response to emerging infectious disease threats and clearly shows th
219 ning for SARS research, as well as for other emerging infectious disease threats that are certain to
221 recedented increase in the number of new and emerging infectious diseases throughout the world, with
222 recent paper published by Lowe and Romney in Emerging Infectious Diseases titled, Bed bugs as Vectors
223 unity patterns has implications ranging from emerging infectious disease to managing host microbiomes
224 blic data sets for the purposes of detecting emerging infectious diseases, to the discovery of novel
225 Consequently it supports the mitigation of emerging infectious diseases transmitted by Aedes aegypt
226 s an attempt to estimate risk factors for an emerging infectious disease using open data and to addre
227 ogenic change is contributing to the rise in emerging infectious diseases, which are significantly co
228 -US Collaborative Program on Emerging and Re-emerging Infectious Diseases, WHO, The Li Ka Shing Oxfor
231 ns, suggesting an important pathway by which emerging infectious diseases will impact not only human
232 Severe acute respiratory syndrome is an emerging infectious disease with high morbidity and mort
233 y syndrome coronavirus (MERS-CoV) is a major emerging infectious disease with zoonotic potential and
234 erally considered rare, a number of recently emerging infectious diseases with load-dependent patholo
235 Immunology, and Clinical Characteristics of Emerging Infectious Diseases With Pandemic Potential (EP
236 ortem examination is especially important in emerging infectious diseases with potentially unknown in
237 lic has become keenly aware of the threat of emerging infectious diseases with the global spread of s